Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 20,000 shares at $24.00 ($480K) on 2023-01-05, disclosed to the SEC on 2023-01-09.
Open-market sale of $480k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 9,556 | $229K | 47.8% |
| 2 | $24.00 | 10,444 | $251K | 52.2% |
| Total | $24.00 avg | 20,000 | $480K | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |